Rapid intrapartum or postpartum HIV testing at a midwife obstetric unit and a district hospital in South Africa
dc.contributor.author | Theron G.B. | |
dc.contributor.author | Shapiro D.E. | |
dc.contributor.author | Van Dyke R. | |
dc.contributor.author | Cababasay M.P. | |
dc.contributor.author | Louw J. | |
dc.contributor.author | Watts D.H. | |
dc.contributor.author | Smith E. | |
dc.contributor.author | Bulterys M. | |
dc.contributor.author | Maupin R. | |
dc.date.accessioned | 2011-05-15T16:16:41Z | |
dc.date.available | 2011-05-15T16:16:41Z | |
dc.date.issued | 2011 | |
dc.description.abstract | Objective: To compare the prepartum and postpartum feasibility and acceptance of voluntary counseling and rapid testing (VCT) among women with unknown HIV status in South Africa. Methods: Eligible women were randomized according to the calendar week of presentation to receive VCT either while in labor or after delivery. Results: Of 7238 women approached, 542 (7.5%) were eligible, 343 (63%) were enrolled, and 45 (13%) were found to be HIV infected. The proportions of eligible women who accepted VCT were 66.8% (161 of 241) in the intrapartum arm and 60.5% (182 of 301) in the postpartum arm, and the difference of 6.3% (95% CI, - 1.8% to 14.5%) was not significant. The median times (44 and 45 minutes) required to conduct VCT were also similar in the 2 arms. In the intrapartum arm, all women in true labor received their test results before delivery and all those found to be HIV positive accepted prophylaxis with nevirapine before delivery. Conclusions: Rapid testing in labor wards for women with an unknown HIV status is feasible and well accepted, and allows for a more timely antiretroviral prophylaxis than postpartum testing. © 2010 International Federation of Gynecology and Obstetrics. | |
dc.description.version | Article | |
dc.identifier.citation | International Journal of Gynecology and Obstetrics | |
dc.identifier.citation | 113 | |
dc.identifier.citation | 1 | |
dc.identifier.issn | 00207292 | |
dc.identifier.other | 10.1016/j.ijgo.2010.10.011 | |
dc.identifier.uri | http://hdl.handle.net/10019.1/13889 | |
dc.subject | nevirapine | |
dc.subject | zidovudine | |
dc.subject | adolescent | |
dc.subject | adult | |
dc.subject | article | |
dc.subject | controlled study | |
dc.subject | feasibility study | |
dc.subject | female | |
dc.subject | HIV test | |
dc.subject | human | |
dc.subject | Human immunodeficiency virus infection | |
dc.subject | intrapartum care | |
dc.subject | labor | |
dc.subject | major clinical study | |
dc.subject | male | |
dc.subject | newborn | |
dc.subject | patient attitude | |
dc.subject | priority journal | |
dc.subject | prophylaxis | |
dc.subject | prospective study | |
dc.subject | puerperium | |
dc.subject | South Africa | |
dc.subject | virus transmission | |
dc.subject | voluntary counseling and rapid testing | |
dc.title | Rapid intrapartum or postpartum HIV testing at a midwife obstetric unit and a district hospital in South Africa | |
dc.type | Article |